Kenneth I. Moch

Companies

• Gamida Cell Ltd.Board member Jan 3, 2022 to Feb 2, 2024¹
• Zynerba PharmaceuticalsBoard member Aug 4, 2015 to Oct 11, 2023²
• Chimerix (United States)Board member Apr 10, 2013 to Apr 7, 2014³
• Chimerix (United States)Chief executive officer Apr 10, 2013 to Apr 7, 2014³
• Chimerix (United States)President Apr 10, 2013 to Apr 7, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GCGamida Cell Ltd.232,300 shares⁴Jan 31, 2024
• ZPZynerba Pharmaceuticals ZYNE0 shares⁵Oct 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 31, 2024Granted 200,000 shares of Gamida Cell Ltd.⁴
• Oct 19, 2023Granted 28,300 shares of Gamida Cell Ltd.⁶
• Oct 10, 2023U 47,824 shares of Zynerba Pharmaceuticals⁵
• Oct 10, 2023U 27,954 shares of Zynerba Pharmaceuticals⁵
• Jun 14, 2023Sold 115 shares at $0.35 of Zynerba Pharmaceuticals⁷
• Jun 13, 2023Granted 47,824 shares of Zynerba Pharmaceuticals⁷
• Feb 8, 2023Granted 28,300 shares of Gamida Cell Ltd.⁸
• Nov 18, 2022Granted 2,000 shares of Gamida Cell Ltd.⁹
• Jun 14, 2022Sold 40 shares at $1.01 of Zynerba Pharmaceuticals¹⁰
• Jun 14, 2022Granted 23,109 shares of Zynerba Pharmaceuticals¹⁰